Please Enter a Search Term
 
"Building a Healthy Tomorrow"  TM
AdmissionsCommunicationsDivision/DisciplineEducationFaculty/StaffLeadershipResearchStudents


Scott Edwards

Oncology
BSc., BSc., (Pharm) Memorial, Pharm.D. Washington

Clinical Assistant Professor Oncology (Pharmaceutical Sciences)

Dr. H. Bliss Murphy Cancer Centre
300 Prince Phillip Dr.
St. John's, NL  A1B 3V6
t: (709) 777-8521
f: (709) 777-2203
lab:

Dr. Scott Edwards Pharm D, MSc (Oncol) is the Clinical Oncology Pharmacy Specialist with the Cancer Care Program in St. John's, Newfoundland and Assistant Professor with Memorial University.
He completed a Bachelor of Neuroscience and Pharmacy at Memorial. He completed his Doctor of Pharmacy degree from the University of Washington. He completed a Master's degree in Oncology from Newcastle University.

He is active in research in the area of chemotherapy toxicities and supportive care.
He is passionate about teaching both undergraduate and postgraduate students.



Courses:

  • Pharmacy 5302     Special Patient Populations  
  • Pharmacy 5104     Therapeutics II, Lecture - Geriatrics, Oncology  
  • Pharmacy 5001     Human Toxicology, Lecture - Toxic Alcohols

Research Interests:

  • Chemotherapy toxicities  
  • Supportive care

Publications

Chia S, Gandhi S, Joy AA, Edwards S, Gorr M, Hopkins S, Kondejewski J, Ayoub JP, Califaretti N, Rayson D, Dent SF. Novel Agents and Associated Toxicities of Inhibitors of the PI3K-Akt-mTOR Pathway for the Treatment of Breast Cancer Current Oncology. Curr Oncol. 2015 Feb;22(1):33-48.

Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, Edwards S, Ensom MH, Foster DR, Hardy B, Kiser TH, la Porte C, Roberts JA, Shulman R, Walker S, Zelenitsky S, Moher D. Reporting Guidelines for Clinical Pharmacokinetic Studies:  The ClinPK Statement. Clin Pharmacokinet. 2015 Jul;54(7):783-95.
 
Edwards SJ, Abbott R, Edwards J, LeBlanc M, Dranitsaris G, Donnan J, Laing K, Whelan MA, MacKinnon NJ. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic. J Pharm Pract. 2014 Feb;27(1):46-52
 
Abbott R, Edwards S, Whelan M, Edwards J, Dranitsaris G. Are community pharmacists equipped to ensure the safe use of oral anti-cancer therapy in the community setting? J Oncol Pharm Pract. 2014 Feb;20(1):29-39
 
Noonan, KL, McCarthy J, Powell E, Laing K, Edwards S, McCrate F. A population-based analysis of patients with early-stage HER2-positive breast cancer in Newfoundland and Labrador. Oncology Exchange Volume 11 (4),2012 Abbott R, Edwards S, Edwards J, Dranitsaris G, McCarthy J. Oral Anti-Cancer Agents in the Community Setting: A Survey of Pharmacists in Newfoundland and Labrador. CPJ Volume 144, Number 5, September/October 2011.
 
Dranitsaris G, Edwards S, Edwards J, Leblanc M, Abbott R. Bevacizumab in combination with folfiri chemotherapy in patients with metastatic colorectal cancer: an assessment of safety and efficacy in the province of Newfoundland and Labrador. Curr Oncol. 2010 Oct;17(5):12-6.
 
Edwards J, Edwards S, Saltman D. The Role of the Nurse Practitioner and Clinical Pharmacist in collaborative patient care and drug therapy management in Canadian cancer centers. Report card on cancer in Canada, 2010-11 Grants Enhancing Knowledge, Quality and Safety of Oral Chemotherapy Delivery & Management in NL Grantor: NL Center for Applied Health Research
Amount: $75000, PI - Kara Laing Scott Edwards

Accomplishments:

Eastern health Allied Health Professional Practice
Clinician of the Year
 2010
Accreditation Canada Leading Practice Award
Oncology Pharmacy toxicity assessments for adjuvant breast cancer patients
 2010
Named to the top 100 Pharmacists in 100 years (1910 to 2010) for Newfoundland  2010
Canadian Society of Hospital Pharmacists (NL Branch)
Leadership in Pharmacy Practice Award
 2009
Award Winning Poster - Pharmacy Practice
National Oncology Pharmacy Symposium
 2005
 2006
 2008
 2010

 

 
Copyright © 2017 Memorial University of Newfoundland.   Newfoundland and Labrador, Canada.